Table 2.
Variable | Patients (n = 11,321) |
---|---|
Any AE, n (%) | 164 (1.4) |
Any SAE, n (%) | 3 (<0.1) |
AE related to treatment, n (%) | 64 (0.6) |
SAE related to treatment, n (%) | 0 (0.0) |
Discontinuations due to AEs, n (%) | 22 (0.2) |
Most frequent AEs, n (%) | |
Dizziness | 27 (0.2) |
Headache | 25 (0.2) |
Edema | 19 (0.2) |
Upper respiratory tract infection | 18 (0.2) |
Cough | 9 (0.1) |
AE adverse event, SAE serious adverse event